In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.
A new review finds AI is transforming thyroid disease care across imaging, pathology, and follow-up, but gaps in generalizability, transparency, and clinical integration persist.